Cepheid India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.11 M
as on 16-11-2024
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 52.48%
(FY 2023)
- Profit -48.72%
(FY 2023)
- Ebitda -39.32%
(FY 2023)
- Net Worth 18.85%
(FY 2023)
- Total Assets 28.04%
(FY 2023)
About Cepheid India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.11 M, as per Ministry of Corporate Affairs (MCA) records.
Ganesh Iyer, Dhiraj Sood, and Santosh Duli serve as directors at the Company.
- CIN/LLPIN
U33110HR2013FTC099516
- Company No.
256833
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
22 Aug 2013
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Cepheid India Private Limited offer?
Cepheid India Private Limited offers a wide range of products and services, including Diagnostic Imaging & Pathology Labs, Medical Test Services, Medical Laboratory Instruments, Rapid Test Kit, PCR Machine.
Who are the key members and board of directors at Cepheid India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ganesh Iyer  | Director | 27-Mar-2020 | Current |
| Dhiraj Sood | Director | 28-Jul-2022 | Current |
| Santosh Duli | Director | 24-Oct-2024 | Current |
Financial Performance and Corporate Structure Insights of Cepheid India.
Cepheid India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 52.48% increase. The company also saw a substantial fall in profitability, with a 48.72% decrease in profit. The company's net worth Soared by an impressive increase of 18.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cepheid India?
In 2023, Cepheid India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cepheid India?
Cepheid India has a workforce of 208 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cepheid India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cepheid India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
